Oh et al. found that inhibition of G9a could reduce HIF-1α stability and VEGF-induced angiogenesis through the VEGFR-2 signaling pathway in hepatocellular carcinoma cells [21]. Here, EHMT2 is linked to hepatocellular carcinoma.